HUAREN MEDICAL TECHNOLOGY
NEWS
Company News
25
2021-12
On December 22, 2021, Yuan Chang'an, secretary of the party group and president of Guangxi Academy of Sciences, Zhou Da, general manager of Guangxi Academy of Sciences High Technology Group, and Yang Dengfeng, researcher of Guangxi Academy of Sciences, went to Huaren Medical Science and Technology Group to visit and research, and investigated Huaren Group's development, technological innovation, and industrial layout, and the leaders of the group accompanied them throughout the whole process.
View More25
2021-12
A new star in tumour cellular immunotherapy: CAR-NK
The treatment of malignant tumours has always been a research hotspot. Although there are many treatment modalities for malignant tumours, their invasiveness and ease of recurrence often make them difficult to be cured and have a very poor prognosis. In recent years, immunotherapy has shown good efficacy in tumour treatment and has received widespread attention.
View More17
2021-12
Warren Medical Experts Reveal Hidden Cancer Causes in the Bowel
Thomas F. Meyer, a consultant expert at Warren Medical Technology Group, recently published an article in Cancer Cell, a prestigious high-level academic journal, reviewing the progress of research related to colistin and cancer. Intestinal colonisation by colistin-producing bacteria is associated with colorectal cancer, and colistin shows a causal relationship in the mutational profile of human cancers. However, this only partially explains the phenomenon of cellular carcinogenesis, and does not adequately reveal that DNA damage leads to genomic mutations and chromosomal instability, which are the main factors of colistin-induced cancers.
View More17
2021-12
What exactly is the secret weapon of Omicron (Omicron), the new mutant strain of New Crown?
According to the Tianjin Epidemic Prevention and Control Command on the 13th, the Tianjin Center for Disease Control and Prevention (TCDC) carried out whole genome sequencing and sequence analysis of respiratory specimens of asymptomatic infected persons with the new coronavirus imported from outside Tianjin on December 9, and after review by the Chinese Center for Disease Control and Prevention (CDC), the detection of the new coronavirus omnicorn variant strain (B.1.1.529 evolutionary branch) was confirmed. The infected person in Tianjin is an inbound closed-loop control person, and is currently under quarantine in a designated hospital for treatment. This is the first time that an omicron variant strain of Neocoronavirus has been detected in Mainland China, and on 15 December, there was a new case of asymptomatic infection associated with the importation of omicron from overseas in Guangzhou.
View More11
2021-12
December 8, 2021, the autonomous region of Science and Technology Department of the party group members, deputy director Jian Xingchao and other 11 people went to Huaren Medical Joint Research and Experimental Center, to help the investigation, field research Huaren Group's development, technological innovation and industrial layout, Huaren Group leaders accompanied throughout.
View More30
2021-11
Hsf1 is a novel target for maintaining HSC adaptation and protein homeostasis
In vitro expansion of haematopoietic stem cells (HSC) has historically been a challenging process.Kruta et al. identified heat shock factor 1 (Hsf1) as a novel target for maintaining HSC fitness and protein homeostasis, not only under culture conditions, but also upon ageing.
View MoreSUBSCRIPTION INFORMATION
We will send you real-time information regularly!
Guangxi Huaren Medical Technology Group Co., Ltd.
Tel: 400-138-8669/ 0771-611-0603
Address: 15th Floor, Building A, Biyuan Center, Wuxiang New District, Nanning City, China (Guangxi) Pilot Free Trade Zone
Huaren Medical Technology
Huaren Medical Research
Hua Ren Cell said